Dong Lin

6.6k total citations
99 papers, 2.9k citations indexed

About

Dong Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dong Lin has authored 99 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 47 papers in Pulmonary and Respiratory Medicine and 22 papers in Cancer Research. Recurrent topics in Dong Lin's work include Prostate Cancer Treatment and Research (38 papers), Cancer-related gene regulation (13 papers) and Ubiquitin and proteasome pathways (8 papers). Dong Lin is often cited by papers focused on Prostate Cancer Treatment and Research (38 papers), Cancer-related gene regulation (13 papers) and Ubiquitin and proteasome pathways (8 papers). Dong Lin collaborates with scholars based in Canada, China and United States. Dong Lin's co-authors include Yuzhuo Wang, Colin C. Collins, Hui Xue, Peter W. Gout, Martin Gleave, Stephen Yiu Chuen Choi, Francesco Crea, Ladan Fazli, Xinpei Ci and Yuwei Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dong Lin

95 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Lin Canada 30 1.7k 1.1k 1.0k 593 210 99 2.9k
Francesco Crea Italy 35 2.5k 1.5× 703 0.6× 1.5k 1.5× 605 1.0× 146 0.7× 88 3.5k
Bora Gürel United States 24 1.4k 0.8× 1.5k 1.4× 722 0.7× 661 1.1× 205 1.0× 57 2.9k
Xi Jin China 26 1.3k 0.7× 668 0.6× 1.0k 1.0× 775 1.3× 326 1.6× 83 2.5k
Chengfei Liu United States 28 1.2k 0.7× 1.3k 1.2× 643 0.6× 519 0.9× 250 1.2× 71 2.6k
Humam Kadara United States 34 1.8k 1.0× 914 0.8× 900 0.9× 1.1k 1.9× 468 2.2× 95 3.2k
Seema Sethi United States 33 1.9k 1.1× 614 0.6× 1.2k 1.2× 957 1.6× 160 0.8× 90 3.1k
Mahmoud Toulany Germany 32 1.9k 1.1× 716 0.6× 603 0.6× 1.1k 1.8× 238 1.1× 59 3.0k
Shancheng Ren China 30 2.1k 1.2× 992 0.9× 1.4k 1.4× 895 1.5× 391 1.9× 78 3.5k

Countries citing papers authored by Dong Lin

Since Specialization
Citations

This map shows the geographic impact of Dong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Lin more than expected).

Fields of papers citing papers by Dong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Lin. The network helps show where Dong Lin may publish in the future.

Co-authorship network of co-authors of Dong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Lin. A scholar is included among the top collaborators of Dong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Lin. Dong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Ning, Hui Xue, Nelson K.Y. Wong, et al.. (2025). Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities. Molecular Cancer Research. 23(4). 327–338.
2.
Kang, Ning, Hui Xue, Yen‐Yi Lin, et al.. (2023). Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer. Cancer Gene Therapy. 30(10). 1382–1389. 6 indexed citations
3.
Zhang, Yong, Ruiqi Wang, Yanan Yang, et al.. (2022). Laurolitsine ameliorates type 2 diabetes by regulating the hepatic LKB1-AMPK pathway and gut microbiota. Phytomedicine. 106. 154423–154423. 16 indexed citations
4.
Mizuno, Kei, Yen‐Yi Lin, Xin Li, et al.. (2021). Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13. Cancer Science. 112(7). 2781–2791. 16 indexed citations
5.
6.
Li, Yan, Wei Wang, Dong Lin, et al.. (2021). Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases. SHILAP Revista de lepidopterología. 15. 100236–100236. 3 indexed citations
7.
Kawai, Yoshihisa, Kenjiro Imada, Shusuke Akamatsu, et al.. (2020). Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer. Molecular Cancer Therapeutics. 19(10). 2210–2220. 12 indexed citations
8.
Ci, Xinpei, Jun Hao, Xin Dong, et al.. (2018). Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer. Cancer Research. 78(10). 2691–2704. 55 indexed citations
9.
10.
Choi, Stephen Yiu Chuen, Hui Xue, Rebecca Wu, et al.. (2016). The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer. Clinical Cancer Research. 22(11). 2721–2733. 79 indexed citations
11.
Shrestha, Raunak, Hui Xue, Yuwei Wang, et al.. (2016). BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer. Clinical Cancer Research. 23(6). 1542–1551. 25 indexed citations
12.
Bishop, Jennifer L., Daksh Thaper, Sepideh Vahid, et al.. (2016). The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer. Cancer Discovery. 7(1). 54–71. 263 indexed citations
13.
Lin, Dong. (2014). Status and Prospect of Medicinal Plant Breeding in China. 4 indexed citations
14.
Lin, Hai, et al.. (2014). Downregulation of caveolin-1 in chronic rhinosinusitis with and without nasal polyps. European Archives of Oto-Rhino-Laryngology. 272(3). 613–618. 3 indexed citations
15.
Lin, Hai, et al.. (2014). Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects. Diagnostic Pathology. 9(1). 15–15. 9 indexed citations
16.
Lin, Dong, Ladan Fazli, Kuo Yang, et al.. (2013). BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells. PLoS ONE. 8(2). e55837–e55837. 30 indexed citations
17.
Johnson, D. T., Richard Luong, Suk Hyung Lee, et al.. (2012). Deletion of Leucine Zipper Tumor Suppressor 2 (Lzts2) Increases Susceptibility to Tumor Development. Journal of Biological Chemistry. 288(6). 3727–3738. 18 indexed citations
18.
19.
Lin, Dong, et al.. (2006). [TPX2 expression and its significance in squamous cell carcinoma of lung].. PubMed. 35(9). 540–4. 6 indexed citations
20.
Lin, Dong, et al.. (2003). Expression of phospho-β-catenin and its significance in non-small cell lung cancer. Chinese Journal of Cancer Research. 15(1). 29–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Crea Breakdown of academic impact, for papers by Bora Gürel Breakdown of academic impact, for papers by Xi Jin Breakdown of academic impact, for papers by Chengfei Liu Breakdown of academic impact, for papers by Humam Kadara Breakdown of academic impact, for papers by Seema Sethi Breakdown of academic impact, for papers by Mahmoud Toulany Breakdown of academic impact, for papers by Shancheng Ren
Rankless by CCL
2026